证券代码：688401 证券简称：路维光电 公告编号：2023-027 深圳市路维光电股份有限公司 关于2023年半年度募集资金存放与实际使用情况 的专项报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 深圳市路维光电股份有限公司（以下简称"公司"）根据中国证券监督管理 委员会《上海证券交易所科创板股票上市规则》（以下简称"《上市规则》"） 《上市公司监管指引第2号——上市公司募集资金管理和使用的监管要求》（以 下简称"《监管指引第2号》"）《上海证券交易所科创板上市公司自律监管指 引第1号——规范运作》（以下简称"《自律监管指引第1号》"）等有关法律法 规和规范性文件的有关规定，现将公司2023年半年度募集资金存放与实际使用情 况报告如下： 一、募集资金基本情况 （一）实际募集资金金额、资金到位情况 根据中国证券监督管理委员会（以下简称"中国证监会"）于2022年7月12 日签发的《关于同意深圳市路维光电股份有限公司首次公开发行股票注册的批 复》（证监许可〔2022〕1476号），并经上海证券交易所同意，公司于202 ...

证券代码：688401 证券简称：路维光电 公告编号：2023-030 深圳市路维光电股份有限公司 关于召开 2023 年第三次临时股东大会的通知 召开日期时间：2023 年 8 月 30 日 14 点 30 分 网络投票系统：上海证券交易所股东大会网络投票系统 网络投票起止时间：自 2023 年 8 月 30 日 至 2023 年 8 月 30 日 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 一、 召开会议的基本情况 （一） 股东大会类型和届次 2023 年第三次临时股东大会 股东大会召开日期：2023年8月30日 本次股东大会采用的网络投票系统：上海证券交易所股东大会网络投票 系统 （二） 股东大会召集人：董事会 （三） 投票方式：本次股东大会所采用的表决方式是现场投票和网络投票相结 合的方式 （四） 现场会议召开的日期、时间和地点 召开地点：深圳市南山区朗山路 16 号华瀚创新园办公楼 D 座 102 公司会议 室 （五） 网络投票的系统、起止日期和投票时间。 采用上海证券交易所网络投票系统，通过 ...

证券代码：688401 证券简称：路维光电 公告编号：2023-026 深圳市路维光电股份有限公司 首次公开发行部分限售股上市流通公告 除战略配售股份外，本次上市流通的限售股数量为61,288,601股。 本次上市流通日期为2023年8月17日。 一、本次上市流通的限售股类型 根据中国证券监督管理委员会于2022年7月12日签发的《关于同意深圳市路 维光电股份有限公司首次公开发行股票注册的批复》（证监许可〔2022〕1476 号），公司首次向社会公开发行人民币普通股（A股）股票33,333,600股，并于 2022 年 8 月 17 日 在 上 海 证 券 交 易 所 科 创 板 上 市 。 公 司 发 行 后 总 股 本 为 133,333,600股，其中有限售条件流通股为104,871,326股，无限售条件流通股 为28,462,274股。 本次上市流通的限售股为公司首次公开发行部分限售股以及部分战略配售 限售股（包含因公司实施2022年年度权益分派，以资本公积金向全体股东每10 股转增4.5股的限售股），锁定期为自公司首次公开发行股票上市之日起12个月。 其中，战略配售限售股份数量为2,876,366股 ...

国信证券股份有限公司 关于深圳市路维光电股份有限公司 首次公开发行部分限售股上市流通的核查意见 国信证券股份有限公司（以下简称"国信证券"或"保荐机构"）作为深圳 市路维光电股份有限公司（以下简称"公司"或"路维光电"）首次公开发行股 票并在科创板上市的保荐机构。根据《中华人民共和国公司法》《中华人民共和 国证券法》《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上 市规则》等有关规定，对公司首次公开发行部分限售股上市流通的事项进行了核 查，核查情况如下： 一、本次上市流通的限售股类型 根据中国证券监督管理委员会（以下简称"中国证监会"）于 2022 年 7 月 12 日签发的《关于同意深圳市路维光电股份有限公司首次公开发行股票注册的 批复》（证监许可〔2022〕1476 号），公司首次向社会公开发行人民币普通股 （A 股）股票 33,333,600 股，并于 2022 年 8 月 17 日在上海证券交易所科创板上 市。公司发行后总股本为 133,333,600 股，其中有限售条件流通股为 104,871,326 股，无限售条件流通股为 28,462,274 股。 本次上市流通的限售股为公司首次公开 ...

证券代码：688401 证券简称：路维光电 公告编号：2023-021 深圳市路维光电股份有限公司 关于参加2022年度半导体专场集体业绩 暨现金分红说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 会议线上交流时间：2023年5月17日（星期三）下午14:00-16:00 会议召开方式：视频和线上文字互动 视 频 和 线 上 文 字 互 动 平 台 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （http://roadshow.sseinfo.com/） 投资者可于2023年5月16日(星期二)16:00前通过邮件、电话、传真等 形式将需要了解和关注的问题提前提供给公司。公司将在文字互动环节对投资 者普遍关注的问题进行回答。 深圳市路维光电股份有限公司（以下简称"公司"）已于2023年4月25日发 布公司2022年年度报告，为便于广大投资者更全面深入地了解公司2022年度经 营成果、财务状况、发展理念，公司参与了由上海证券交易所主办的2022年度 半导体专场集体业绩说明会，此次活动将 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥135,909,244.13, representing a decrease of 6.23% compared to the same period last year[5]. - Net profit attributable to shareholders was ¥28,413,758.53, an increase of 77.18% year-on-year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥23,494,281.44, up 73.27% from the previous year[5]. - Basic earnings per share were ¥0.21, reflecting a growth of 31.25% year-on-year[6]. - Net profit for Q1 2023 reached CNY 24,234,876.93, an increase of 119.5% compared to CNY 11,041,388.08 in Q1 2022[21]. - Basic and diluted earnings per share for Q1 2023 were CNY 0.21, up from CNY 0.16 in Q1 2022[21]. Cash Flow - The net cash flow from operating activities reached ¥60,475,025.15, a significant increase of 1,247.01% compared to the same period last year[5]. - Cash received from operating activities totaled ¥193,729,198.49, compared to ¥127,661,894.64 in the previous period[24]. - Cash inflow from financing activities totaled ¥100,100,000.00, with a net cash inflow of ¥85,284,011.64 after outflows of ¥14,815,988.36[25]. - The net increase in cash and cash equivalents for the period was ¥12,617,579.22, compared to a net decrease of ¥39,316,636.42 in the previous period[25]. - The ending balance of cash and cash equivalents was ¥629,822,268.17, up from ¥617,204,688.95 at the beginning of the period[25]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,086,922,925.23, an increase of 7.73% from the end of the previous year[6]. - Total liabilities for Q1 2023 were CNY 668,922,262.67, an increase of 23.1% from CNY 543,590,197.79 in Q1 2022[18]. - Non-current liabilities totaled CNY 342,841,290.36, up from CNY 245,904,439.46 in Q1 2022[18]. - Total current assets as of March 31, 2023, amounted to CNY 1,104,065,851.07, a decrease from CNY 1,120,819,479.97 as of December 31, 2022, reflecting a decline of approximately 1.48%[16]. - The company's inventory increased significantly to CNY 155,813,272.94 from CNY 109,609,130.92, representing an increase of about 42.14%[16]. Research and Development - Research and development expenses totaled ¥7,920,288.99, accounting for 5.83% of operating revenue, which is an increase of 1.53 percentage points[6]. - Research and development expenses for Q1 2023 were CNY 7,920,288.99, an increase of 27% compared to CNY 6,237,999.94 in Q1 2022[20]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 6,455[11]. - The company reported a total of 3,420,000 shares held by its largest shareholder, indicating significant ownership concentration[12]. Other Information - The company has not disclosed any new product or technology developments in the current report[15]. - There are no significant mergers or acquisitions reported during the quarter[15]. - The company has not provided specific future guidance or outlook in the current report[15]. - The report indicates that there are no applicable audit opinions for the financial statements[15]. - The company implemented new accounting standards starting January 1, 2023, affecting the financial statements[25].

Financial Performance - The company reported a total revenue of RMB 1.5 billion for the year 2022, representing a year-over-year increase of 15%[14]. - The company's operating revenue for 2022 was CNY 640,013,669.67, representing a year-on-year increase of 29.66% compared to CNY 493,591,729.76 in 2021[24]. - The net profit attributable to shareholders for 2022 reached CNY 119,775,263.96, a significant increase of 128.99% from CNY 52,306,374.77 in 2021[24]. - The net cash flow from operating activities was CNY 298,560,302.33, showing a year-on-year growth of 122.05% compared to CNY 134,455,409.37 in 2021[24]. - The gross margin for 2022 was reported at 35%, a slight increase from 33% in the previous year[14]. - The basic earnings per share for 2022 was CNY 1.08, up 107.69% from CNY 0.52 in 2021[25]. - The company achieved a market share of 19.21% in the G11 mask segment in 2021, up from 13.97% in 2020, ranking fourth globally in sales revenue[62]. - The company reported a revenue increase of 15% year-over-year, reaching $500 million in the last quarter[168]. Dividend and Capital Plans - The company plans to distribute a cash dividend of 2.2 CNY per 10 shares, totaling approximately 29.33 million CNY, which represents 24.49% of the net profit attributable to shareholders for the year 2022[5]. - The company intends to increase its share capital by 4.5 shares for every 10 shares held, resulting in a total share capital of approximately 193.33 million shares after the increase[6]. - The company's profit distribution plan has been approved by the board and is pending approval from the shareholders' meeting[6]. - The company has established a cash dividend policy that requires a minimum of 10% of the distributable profit to be distributed as cash dividends when certain conditions are met[193]. Research and Development - The company invested RMB 200 million in R&D for new technologies, focusing on Mini-LED and Micro-LED advancements[16]. - Research and development expenses accounted for 4.44% of operating revenue in 2022, slightly down from 4.66% in 2021[25]. - The company achieved a research and development investment of CNY 28.42 million, a year-on-year increase of 23.57%, accounting for 4.44% of total revenue[83]. - The company has developed 5 new core process technologies during the reporting period, bringing the total to 28 core technologies[79]. - The company is actively pursuing market expansion and technological innovation to enhance its competitive edge in the industry[82]. Market Expansion and Strategic Initiatives - Market expansion efforts are underway in Southeast Asia, targeting a 30% increase in market penetration by 2024[15]. - The company completed an acquisition of a local competitor for RMB 500 million, expected to enhance production capabilities[16]. - A new strategic partnership was formed with a leading semiconductor supplier to improve supply chain efficiency[15]. - The company is considering strategic acquisitions to enhance its market position, with a budget of $100 million allocated for potential deals[168]. - The company plans to continue expanding its market presence and investing in new product development[115]. Operational Risks and Governance - The company has outlined various operational risks and corresponding countermeasures in the report[4]. - The board of directors has confirmed the authenticity, accuracy, and completeness of the annual report, assuming legal responsibility for any misstatements[4]. - The company has not reported any significant adverse effects from competition with its controlling shareholder[161]. - The company has maintained a stable governance structure with no significant changes in the independence of its operations from the controlling shareholder[161]. - The company is committed to ongoing improvements in its internal control systems to further enhance governance levels[160]. Employee and Management Information - The total number of employees in the parent company and major subsidiaries is 308, with 161 in production, 29 in sales, 44 in technology, 17 in finance, and 57 in administration[188]. - The company has a training plan in place that combines internal and external training to enhance employee skills and overall capabilities[191]. - The total remuneration for the chairman and general manager, Du Wubing, is 940,600 RMB, with no change in shareholding during the reporting period[165]. - The total remuneration for all directors, supervisors, and senior management at the end of the reporting period amounted to CNY 3,602,182.24[177]. - The company has no ongoing employee stock ownership plans or other incentive measures reported during the period[199]. Financial Position and Risks - The total assets as of the end of 2022 amounted to CNY 1,937,255,983.42, reflecting a 47.95% increase from CNY 1,309,440,280.43 in 2021[24]. - The company relies heavily on imports for key raw materials, with 86.88% of raw material purchases coming from the top five suppliers, which poses a supply risk[102]. - Accounts receivable at the end of the reporting period amounted to 141.42 million yuan, representing 22.10% of revenue, indicating potential collection risks[103]. - The company faces risks from increasing competition in the mask plate industry, particularly from international players as the market demand grows[105]. - The company is exposed to macroeconomic risks, as its performance is closely tied to the health of the downstream electronics industry and global economic conditions[106].

Financial Performance - The company's operating revenue for Q3 2022 reached ¥199,151,395.88, representing a year-on-year increase of 31.21%[3] - Net profit attributable to shareholders for Q3 2022 was ¥39,053,676.13, a significant increase of 104.74% compared to the same period last year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2022 was ¥36,566,542.83, up 78.65% year-on-year[3] - Basic earnings per share for Q3 2022 were ¥0.35, representing an increase of 84.21% compared to the same period last year[4] - Operating profit for the third quarter of 2022 was ¥89,554,037.48, compared to ¥26,401,897.83 in the third quarter of 2021, reflecting a significant increase[22] - Net profit for the first three quarters of 2022 was ¥76,216,258.90, up from ¥17,130,658.24 in the same period of 2021, indicating a strong growth trajectory[22] - The net profit attributable to the parent company's shareholders for Q3 2022 was ¥85,132,910.44, compared to ¥37,361,526.41 in Q3 2021, representing a significant increase[23] - The total comprehensive income attributable to the parent company's owners for Q3 2022 was ¥85,132,910.44, compared to ¥37,361,526.41 in Q3 2021[23] Assets and Liabilities - The total assets of the company as of the end of Q3 2022 amounted to ¥2,069,004,090.88, reflecting a growth of 58.01% compared to the end of the previous year[4] - Total assets as of September 30, 2022, amounted to ¥2,069,004,090.88, compared to ¥1,309,440,280.43 at the end of 2021, representing a 58.1% increase[19] - Current assets totaled ¥1,273,896,233.07 as of September 30, 2022, significantly higher than ¥473,921,610.70 at the end of 2021, marking a 168.5% increase[18] - Total liabilities decreased to ¥709,939,413.58 from ¥787,102,345.61, a reduction of approximately 9.8%[19] - The company's total equity reached ¥1,359,064,677.30, a significant increase from ¥522,337,934.82, indicating strong financial health[19] Cash Flow - The cash flow from operating activities for the year-to-date period reached ¥186,656,082.77, showing a year-on-year increase of 118.06%[4] - The net cash flow from operating activities for the first three quarters of 2022 was ¥186,656,082.77, up from ¥85,599,406.49 in the same period of 2021, indicating a growth of approximately 118.5%[25] - The company reported a total cash inflow from operating activities of ¥544,712,888.15 for the first three quarters of 2022, compared to ¥357,482,946.74 in the same period of 2021[25] - The total cash inflow from financing activities in the first three quarters of 2022 was ¥869,743,362.38, compared to ¥95,000,000.00 in the same period of 2021, showing a substantial increase of about 815.5%[26] - The company's cash and cash equivalents increased to ¥990,027,800.48 from ¥148,963,859.99, a remarkable growth of 564.5%[17] - The cash and cash equivalents at the end of Q3 2022 amounted to ¥990,007,800.48, a significant increase from ¥128,538,646.56 at the end of Q3 2021[26] - The company’s cash flow from financing activities netted ¥745,030,661.84 in the first three quarters of 2022, a significant increase from ¥7,957,372.66 in the same period of 2021[26] Research and Development - The company's R&D investment for Q3 2022 was ¥8,458,407.98, which is an increase of 63.95% year-on-year, indicating a focus on new product and technology development[4] - Research and development expenses for the third quarter of 2022 were ¥22,088,083.09, up from ¥15,674,454.74 in the same quarter of 2021, indicating a focus on innovation[22] Market and Future Outlook - The company plans to continue expanding its market presence, contributing to the growth in revenue and profit margins[8] - The increase in revenue and profit is attributed to enhanced sales and scale effects, driven by market expansion efforts[8] - Future outlook remains cautious, with no specific guidance provided for the upcoming quarters[12] - The company has not disclosed any major market expansion or acquisition strategies in the current report[12] - The report indicates that the company has no significant new product launches or technological advancements mentioned in the current quarter[12] - The report does not indicate any significant changes in the competitive landscape or regulatory environment affecting the company[12] Shareholder Information - Shenzhen Luweixing Investment Co., Ltd. reported a total investment of 10,147,800 RMB, with a share price of 7.61 RMB[12] - The company also noted an investment of 9,000,000 RMB from Guotou (Shanghai) Venture Capital Management Co., Ltd., with a share price of 6.75 RMB[12] - Shenzhen Xingsen Quick Circuit Technology Co., Ltd. reported an investment of 7,700,600 RMB, with a share price of 5.78 RMB[12] - The company highlighted a user base increase, with 1,900,000 shares pledged by individual investors[12] - The top shareholder, UBS AG, holds 17,852,825 shares, representing 1.06% of the total shares of Shenzhen Xingsen Quick Circuit Technology Co., Ltd.[15]